Cardiothoracic & vascular anesthesia
On-Table Extubation following Cardiac Surgery: Clinical Outcomes and Associated Cost Reductions from a Single Academic Medical Center
Authors' conclusion
OTE is a safe and effective alternative to EE in appropriately selected cardiac surgery patients, associated with shorter hospitalization and reduced cost without compromising patient safety.
Study context
- Population
- Patients who underwent cardiac surgery between January 2020 and December 2023 at a single US academic medical center1,026 (50.9%) on-table extubation (OTE)
- Participants
- 2,014 patients
- Exposure
- On-table extubation vs early extubation after cardiac surgery
- OTEn = 1,026
- Outcome
- Hospital LOS and direct hospital costs
Methodological detailsobservational, single-centre, adjusted for baseline characteristics
- Observational
- Single-centre
- Adjusted for baseline characteristics
Main finding
As reported in the abstract
Regression coefficient (hospital LOS)
−0.78 days
95% CI −1.2 to −0.36P < 0.001
OTE
Regression coefficient (direct hospital costs)
-$3,029
95% CI -$4,831 to -$1,227P = 0.001
OTE
Observational data: associations, not effects.
Safety
Reintubation, ICU readmission, discharge mortality, 30-day mortality, initial ICU hours
- No significant differences between groups
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →